Las Vegas, NV – June 17, 2014 — (TechSonian) – Puramed Bioscience Inc (OTCMKTS:PMBS) develops and markets proprietary non-prescription medicinal and healthcare products in the United States. It offers LipiGesic M to treat migraine headaches; LipiGesic H for tension-type headaches; and LipiGesic PM for the treatment of insomnia and other sleep disorders. The company focuses on marketing its products through various retail channels. PuraMed BioScience, Inc. is based in Schofield, Wisconsin.
Puramed Bioscience Inc (OTCMKTS:PMBS) traded 57.05 million shares in the last business day while the average volume of the stock remained 1629.50 million shares. The stock showed anegative movement of -25.00% to end at $0.0009.
Everything I post in my opinion only and should not be taken as a suggestion to buy or sell
Do your own Due Diligence
